A Landmark Recognition in Natural and Medicinal Chemistry: The 2024 Tu Youyou Award Celebrates Pioneering Researchers
But here's where it gets controversial—what truly drives groundbreaking advances in natural products and drug discovery? Perhaps recognition, such as the prestigious Tu Youyou Award, is one of the key catalysts inspiring innovation, pushing scientists to unveil new therapies that can transform healthcare worldwide.
Recently, two outstanding scholars earned this accolade for their extraordinary contributions to their respective fields of expertise. On October 3, 2025, during a ceremony held in Chicago, Professors Richard DiMarchi and Rolf Müller were honored as the 2024 laureates of the Tu Youyou Award, an honor named after the Nobel Prize laureate in Physiology or Medicine from 2015. This award, established to celebrate excellence in natural products chemistry and medicinal chemistry, underscores the ongoing importance of these disciplines in advancing human health.
Celebrating Scientific Excellence
Professor Richard DiMarchi, a distinguished figure in medicinal chemistry and holder of the Gill Chair of Biomolecular Sciences at Indiana University, was recognized for his pioneering efforts that contributed to the development of critical therapeutics for diabetes and obesity. His work on innovative drugs like Humalog, Humulin, rGlucagon, and Forteo has revolutionized the treatment landscape. These breakthroughs have deepened our understanding of hormones such as glucagon and incretins, leading to therapies that significantly improve patient outcomes.
In his own words, Professor DiMarchi shared his admiration for Professor Tu Youyou's dedication, stating, “Her unwavering commitment to science and patient care has been a major inspiration to me. It’s an honor to receive recognition, which also credits the hard work of my colleagues.” He added that the success with incretin-based treatments represents a shift in pharmaceutical thinking—from merely reacting to diseases to actively promoting health and preventing problems before they arise. In fact, he sees a growing trend where individuals are focusing more on lifestyle choices like diet and exercise, which could someday complement or even replace certain peptide-based therapies. “If our work has influenced this mindset change in any way, I consider it a victory,” he remarked.
Meanwhile, Professor Rolf Müller, managing director of the Helmholtz Institute for Pharmaceutical Research Saarland and a leading researcher in microbiology and natural products, was acknowledged for his over 20 years of exploration into microbial biosynthetic pathways. His focus on bacteria such as myxobacteria and soil-dwelling microbes has opened doors to new pharmaceuticals. Notably, his team has developed potent anti-tuberculosis drugs like Griselimycin and promising treatments for parasitic diseases such as filariasis—including Corallopyronin A. His research emphasizes the vast, largely untapped potential of microbial natural products in discovering new antibiotics—an urgent need considering the rising challenge of antimicrobial resistance.
Expressing his gratitude, Professor Müller stated, “This award is a recognition of my team’s dedication, and we are proud to honor Professor Tu Youyou’s legacy, who is one of the greatest success stories in natural product development. Our society desperately needs new antibiotics, and both academia and industry must work collaboratively and innovatively to keep pace. Industry has shifted away from natural product research, so academic research now plays an even more vital role. We need policies that incentivize partnerships since sustainable development depends on public-private collaborations that are financially viable for all involved.
